Legislation


HB 18 (see companion bill SB 604) – Hawaii

Status: Inactive / Dead
Year Introduced: 2021
Link: https://www.capitol.hawaii.gov/measure_indiv.aspx?billtype=HB&billnumber=18&year=2022

Requires the Insurance Commissioner to set the maximum wholesale prices of common prescription drugs based upon Canadian price regulations. Prohibits drug makers and distributors from removing prescription drugs from Hawaii markets. Prohibits various health plans and pharmacies from purchasing prescription drugs in excess of the maximum wholesale price.


Return to Database Search

© 2018-2019 The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found